The α2 antagonist idazoxan remediates certain attentional and executive dysfunction in patients with dementia of frontal type

Psychopharmacology

Volumn 123, Issue 3, 1996, Pages 239-249

  Coull, J T ^a,d   Sahakian, B J ^b   Hodges, J R ^c  

^a UK   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cognitive enhancer; Executive function; Frontal cortex; Frontal dementia; Idazoxan; Memory; 2 Adrenoceptor

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; IDAZOXAN; PLACEBO;

ADULT; AGED; ARTICLE; ATTENTION; CASE REPORT; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DOUBLE BLIND PROCEDURE; FEMALE; FRONTAL CORTEX; HUMAN; MALE; MEMORY; NEUROPSYCHOLOGICAL TEST; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SPATIAL MEMORY; WORKING MEMORY;

EID: 0030045515     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02246578     Document Type: Article

References (64)

1. Abraham WC, Delanoy RL, Dunn AJ, Zornetzer SF (1979) Locus coeruleus stimulation decreases deoxyglucose uptake in ipsilateral cerebral cortex. Brain Res 172:387-392
2. Arnsten AFT, Cai JX (1994) Postsynaptic alpha-2 receptor stimulation improves memory in aged monkeys: indirect effects of yohimbine versus direct effects of clonidine. Neurobiol Aging 14:597-603
3. Arnsten AFT, Goldman-Rakic PS (1985) Alpha-2 adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates. Science 230:1273-1276
4. Aston-Jones G, Chiang C, Alexinsky T (1991) Discharge of noradrenergic locus coeruleus neurons in behaving rats and monkeys suggest a role in vigilance. In: Barnes CD, Pompeiano O (eds) Progress in brain research, vol. 88. Elsevier Science Publishers, Amsterdam, pp 501-520
5. Baddeley A (1986) Working memory. Oxford University Press, Oxford
6. 2-adrenoceptor involvement in the central cardiovascular action of clonidine in the conscious renal hypertensive cat. Eur J Pharmacol 82: 155-160
7. Benton AL (1968) Differential effects of frontal lobe disease. Neuropsychologia 6:53-60
8. Bricca G, Dontenwill M, Molines A, Feldman J, Belcourt A, Bousquet P (1989) The imidazoline preferring receptor: binding studies in bovine, rat and human brainstem. Eur J Pharmacol 162:1-9
9. Cohen RM, Semple WE, Gross M, Holcomb HJ, Dowling S, Nordahl TE (1988) Functional localization of sustained attention. Neuropsychiat Neuropsychol Behav Neurol 1:3-20
10. Coull JT, Middleton HC, Robbins TW, Sahakian BJ (1995a) Contrasting effects of clonidine and diazepam on tests of working memory and planning. Psychopharmacology 120:311-321
11. Coull JT, Middleton HC, Robbins TW, Sahakian BJ (1995b) Clonidine and diazepam have differential effects on tests of attention and learning. Psychopharmacology 120:322-332
12. Davies DR, Parasuraman R (1982) The Psychology of vigilance. Academic Press, London
13. 2-adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline (as measured by in vivo dialysis) in the rat. J Pharmacol Exp Ther 241:642-649
14. De Vos H, Bricca G, De Keyser J, De Backer JP, Bousquet P, Vauquelin G (1994) Imidazoline receptors, non-adrenergic idazoxan binding sites and alpha-2 adrenoceptors in the human central nevous system. Neuroscience 59:589-598
15. Downes JJ, Roberts AC, Sahakian BJ, Evenden JL, Morris RG, Robbins TW (1989) Impaired extradimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction. Neuropsychologia 27:1329-1344
16. 2 adrenoceptors. Br J Pharmacol 78:489-505
17. Elfgren C, Passant U, Risberg J (1993) Neuropsychological findings in frontal lobe dementia. Dementia 4:214-219
18. Fields RB, van Kammen DP, Peters JL, Rosen J, Van Kammen WB, Nugent A, Stipetic M, Linnoila M (1988) Clonidine improves memory function in schizophrenia independently from change in psychosis: preliminary findings. Schizophr Res 1:417-423
19. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
20. Francis PT, Holmes C, Webster MT, Stratmann GC, Procter AW, Bowen DM (1993) Preliminary neurochemical findings in non-Alzheimer dementia due to lobar atrophy. Dementia 4:172-177
21. Friedland RP, Koss E, Lerner A, Hedera P, Ellis W, Dronkers N, Ober BA, Jagust WJ (1993) Functional imaging, the frontal lobes and dementia. Dementia 4:192-203
22. Frith CD (1987) The positive and negative symptoms of schizophrenia reflect impairments in the perception and initiation of action. Psychol Med 17:631-648
23. Gallagher M, Kapp BS, Musty RE, Driscoll PA (1977) Memory formation: evidence for a specific neurochemical system in the amygdala. Science 198:423-425
24. Glue P, Wilson S, Lawson C, Campling GM, Franklin M, Cowen PJ, Nutt DJ (1991) Acute and chronic idazoxan in normal volunteers: biochemical, physiological and psychological effects. J Psychopharmacol 5:396-403
25. Gregory CA, Hodges JR (1993) Dementia of frontal type and the focal lobar atrophies. Int Rev Psychiatry 5:397-406
26. Gustafson L (1993) Clinical picture of frontal lobe degeneration of non-Alzheimer type. Dementia 4:143-148
27. Jones GMM, Sahakian BJ, Levy R, Warburton DM, Gray JA (1992) Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology 108:485-494
28. Krystal JH, McDougle CJ, Woods SW, Price LH, Heninger GR, Charney DS (1992) Dose-response relationships for oral idazoxan effects in healthy human subjects: comparison with oral yohimbine. Psychopharmacology 108:313-319
29. Langer SZ, Cavero I, Massinham R (1980) Recent developments in noradrenergic neurotransmission and its relevance to the mechanism of action of certain antihypertensive agents. Hypertension 2:372-382
30. Liddle PF (1987) Schizophrenic syndromes, cognitive performance and neurological dysfunction. Psychol Med 17:49-57
31. 2 antagonist, augments fluphenazine in schizophrenic patients: a pilot study. J Clin Psychopharmacol 13:264-267
32. McNicol D (1972) A primer of signal detection theory. George Allen and Unwin, London
33. Mair RG, McEntee WJ (1986) Cognitive enhancement in Korsakoff's pyschosis by clonidine: a comparison with L-dopa and ephedrine. Psychopharmacology 88:374-380
34. Middleton HC, Coull JT, Sahakian BJ, Robbins TW (1994) Clonidine-induced changes in the spectral distribution of heart-rate variability correlate with performance on a test of sustained attention. J Psychopharmacol 8:1-7
35. Milner B (1964) Some effects of frontal lobectomy in man. In: Warren JM, Akert K (eds) The frontal granular crotex and behaviour. McGraw-Hill, New York, pp 313-331
36. Neary D (1989) Non-Alzheimer dementia. Curr Opin Neurol Neurosurg 2:457-459
37. Neary D, Snowden JS, Northern B, Goulding PJ (1988) Dementia of frontal lobe type. J Neurol Neurosurg Psychiatry 51: 353-361
38. Nelson HE (1982) National adult reading test manual. NFER-Nelson, Windsor, Berks
39. Orrell MW, Sahakian BJ (1991) Dementia of frontal lobe type. Psychol Med 21:553-556
40. Owen AM, Downes JJ, Sahakian BJ, Polkey CE, Robbins TW (1990) Planning and spatial working memory following frontal lobe lesions in man. Neuropsychologia 29:993-1006
41. Owen AM, Morris RG, Sahakian BJ, Polkey CE, Robbins TW (1995a) Double dissociations of memory and executive functions in working memory tasks following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man. Brain (in press)
42. Owen AM, Sahakian BJ, Semple J, Polkey CE, Robbins TW (1995b) Visuo-spatial short-term recognition memory and learning after temporal lobe excisoins, frontal lobe excisions or amygdalohippocampectomy in man. Neuropsychologia 33:1-24
43. Robbins TW (1984) Cortical noradrenaline, attention and arousal. Psychol Med 14:13-21
44. Sahakian BJ, Joyce E, Lishman WA (1987) Cholinergic effects on constructional abilities and on mnemonic processes: a case report. Psychol Med 17:329-333
45. Sahakian BJ, Morris RGM, Evenden JL, Heald A, Levy R, Philpot M, Robbins TW (1988) A comparative study of visuospatial memory and learning in Alzheimer type dementia and Parkinson's disease. Brain 111:695-718
46. Sahakian BJ, Jones GMM, Levy R, Gray JA, Warburton DM (1989) The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type Br J Psychiatry 154:797-800
47. Sahakian BJ, Owen AM, Morant NJ, Eagger SA, Boddington S, Crayton L, Crockford HA, Crooks M, Levy R (1993) Further analysis of the cognitive effects of tetrahydroaminoacradine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB. Psychopharmacology: 110:395-401
48. Sahgal A (1987) Some limitations of indices derived from signal detection theory: evaluation of an alternative index for measuring bias in memory tasks. Psychopharmacology 91: 517-520
49. Sahgal A, Sahakian BJ, Robbins TW, Wray CJ, Lloyd S, Cook JH, McKeith IG, Disley JCA, Eagger S, Boddington S, Edwardson JA (1991) Detection of visual memory and learning deficits in Alzheimer's disease using the Cambridge Neuropsychological Test Automated Battery. Dementia 2:150-158
50. Schmidt M, Matochik J, Risinger R, Zametkin A, Schouten J, Cohen R, Potter W (1994) Effects of idazoxan on regional brain metabolism. Abstract for American Society for Clinical Pharma-cology and Therapeutics, Spring meeting
51. Shallice T (1982) Specific impairments in planning. Philos Trans R Soc Lond B298:199-209
52. 2-adrenoceptor antagonist idazoxan on mood, memory and attention in normal volunteers. J Psychopharmacol 6:376-381
53. Stein L, Belluzzi JD, Wise CD (1975) Memory enhancement by central administration of norepinephrine. Brain Res 84:329-335
54. Sunderland T, Tariot PN, Mueller EA, Murphy DL, Weingartner H, Cohen RM (1985) Cognitive and behavioural sensitivity to scopolamine in Alzheimer patients and controls. Psychopharmacol Bull 21:676-679
55. Sunderland T, Tario PN, Weingartner H, Murphy DL, Newhouse PA, Mueller EA, Cohen RM (1986) Pharmacological modelling of Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 10:599-619
56. Trenerry MR, Jack CR, Ivnik RJ, Sharbrough FW, Cascino GD, Hirschorn KA, Marsh WR, Kelly PJ, Meyer FB (1993) MRI hippocampal volumes and memory function before and after temporal lobectomy. Neurology 43:1800-1805
57. Troster AI, Butters N, Salmon DP, Cullum CM, Jacobs D, Brandt J, White RF (1993) The diagnostic utility of savings scores: differentiating Alzheimer's and Huntington's disease with the logical memory and visual reproduction tests. J Clin Exp Neuropsychol 15:773-788
58. Wechsler D (1955) Wechsler adult intelligence scale. The Psychological Corporation, New York
59. Wechsler D (1987) Wechsler memory scale - revised. The Psychological Corporation, Harcourt Brace Jovanovich, New York
60. Wesnes K, Warburton DM (1984) Effects of scopolamine and nicotine on human rapid information processing performance. Psychopharmacology 82:147-150
61. Wilkins AJ, Shallice T, McCarthy R (1987) Frontal lesions and sustained attention. Neuropsychologia 25:359-365
62. Wilson B, Cockburn J, Baddeley AD (1985) Rivermead behavioural memory test. Thames Valley Test, Titchfield, Fareham
63. Woods DL, Knight RT (1986) Electrophysiologic evidence of increased distractability after dorsolateral prefrontal lesions. Neurology 36:212-216
64. Woods SW, Hoffer PB, McDougle CJ, Krystal JH, Heninger GR, Charney DS (1991) Effects of yohimbine on regional cerebral blood flow in panic disorder. Soc Neurosci Abstr 17:293.8